richard lipton, md, director, montefiore headache center; edwin s. lowe professor and vice chairman of neurology, albert einstein college of medicine..-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018..
.
.
drag according to your convenience .
refrain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks, name calling or inciting hatred against any community.